Cardiovascular disease in diabetes, beyond glucose

被引:117
|
作者
Eckel, Robert H. [1 ,2 ]
Bornfeldt, Karin E. [3 ,4 ]
Goldberg, Ira J. [5 ]
机构
[1] Univ Colorado, Div Endocrinol Metab & Diabet, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA
[2] Univ Colorado, Div Cardiol, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA
[3] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA
[4] Univ Washington, Dept Lab Med & Pathol, Med Diabet Inst, Seattle, WA 98195 USA
[5] NYU, Div Endocrinol Diabet & Metab, Grossman Sch Med, New York, NY USA
关键词
CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; PRESSURE-LOWERING TREATMENT; INTENSIVE GLYCEMIC CONTROL; IMPAIRED FASTING GLUCOSE; SYSTOLIC BLOOD-PRESSURE; ALL-CAUSE MORTALITY; 10-YEAR FOLLOW-UP; INSULIN-RESISTANCE; RISK-FACTORS;
D O I
10.1016/j.cmet.2021.07.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Despite the decades-old knowledge that diabetes mellitus is a major risk factor for cardiovascular disease, the reasons for this association are only partially understood. While this association is true for both type 1 and type 2 diabetes, different pathophysiological processes may be responsible. Lipids and other risk factors are indeed important, whereas the role of glucose is less clear. This lack of clarity stems from clinical trials that do not unambiguously show that intensive glycemic control reduces cardiovascular events. Animal models have provided mechanisms that link diabetes to increased atherosclerosis, and evidence consistent with the importance of factors beyond hyperglycemia has emerged. We review clinical, pathological, and animal studies exploring the pathogenesis of atherosclerosis in humans living with diabetes and in mouse models of diabetes. An increased effort to identify risk factors beyond glucose is now needed to prevent the increased cardiovascular disease risk associated with diabetes.
引用
收藏
页码:1519 / 1545
页数:27
相关论文
共 50 条
  • [1] Preventing cardiovascular disease in diabetes and glucose intolerance: evidence and implications for care
    Rennert, NJ
    Charney, P
    PRIMARY CARE, 2003, 30 (03): : 569 - +
  • [2] Cardiovascular Disease in Diabetes and Chronic Kidney Disease
    Swamy, Sowmya
    Noor, Sahibzadi Mahrukh
    Mathew, Roy O.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
  • [3] New approach to diabetes care: from blood glucose to cardiovascular disease
    Aguiar, Carlos
    Duarte, Rui
    Carvalho, Davide
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2019, 38 (01) : 53 - 63
  • [4] Primary and Secondary Prevention Strategy for Cardiovascular Disease in Diabetes Mellitus
    Srikanth, Sundararajan
    Deedwania, Prakash
    CARDIOLOGY CLINICS, 2011, 29 (01) : 47 - +
  • [5] Normal fasting plasma glucose predicts type 2 diabetes and cardiovascular disease in elderly population in Taiwan
    Huang, C. -L.
    Chang, H. -W.
    Chang, J. -B.
    Chen, J. -H.
    Lin, J. -D.
    Wu, C. -Z.
    Pei, D.
    Hung, Y. -J.
    Lee, C. -H.
    Chen, Y. -L.
    Hsieh, C. -H.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (08) : 515 - 522
  • [6] Cardiovascular Disease in Adults with Type 1 Diabetes: Looking Beyond Glycemic Control
    Miller, Rachel G.
    Costacou, Tina
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (10) : 1467 - 1475
  • [7] Cardiovascular Disease in Diabetes: Where Does Glucose Fit In?
    Reusch, Jane E. B.
    Wang, Cecilia C. Low
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (08): : 2367 - 2376
  • [8] Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?
    Mannucci, Edoardo
    Dicembrini, Ilaria
    Lauria, Angelo
    Pozzilli, Paolo
    DIABETES CARE, 2013, 36 : S259 - S263
  • [9] Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
    Ferrannini, Ele
    DeFronzo, Ralph A.
    EUROPEAN HEART JOURNAL, 2015, 36 (34) : 2288 - U19
  • [10] CARDIOVASCULAR DISEASE AND DIABETES
    Mangiapane, Heather
    DIABETES: AN OLD DISEASE, A NEW INSIGHT, 2013, 771 : 219 - 228